TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.

Natalia Palazón-Carrión et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.